Canopy Growth and Spectrum Therapeutics Expand Medical Portfolio with New 30 and 90-Pack Softgels and Enhanced Dosing Options

Thursday, May 7, 2026

AI Briefing

Canopy Growth and Spectrum Therapeutics introduce new 30 and 90-pack softgel formats and enhanced dosing options for its Minor Cannabinoid Optimized Spectrum portfolio.
The expansion builds on the success of existing 30-pack formats and aims to improve patient access.
A new dosing option is also being added to its lineup, reflecting the company's commitment to providing more targeted treatment options.